II. Management: Exacerbating factors to avoid
- Medications that exacerbate acne
- Androgenic steroids (e.g. Danazol, Testosterone
- Corticosteroids
- Lithium
- Oral Contraceptives
- Isoniazid
- Phenytoin (Dilantin)
- Environment
- Hot
- Greasy (fast-food kitchen, garage)
- Tobacco smoke exposure
- Oil based Cosmetics (Acne cosmetica)
- Emotional Stress
- Physical Pressure (acne mechanica)
- Tight chinstrap
- Helmet
- Refined Carbohydrates (high Glycemic Index foods)
- Sweets, Chocolate and pizza do in fact worsen Acne Vulgaris, despite prior dogma
- fiedler (2017) acta derm venereol 97(1):7-9 +PMID:27136757 [PubMed]
- mahmood (2014) J Drugs Dermatol 13(4): 428-35 +PMID:24719062 [PubMed]
III. Management: Myths (non-causes of Acne Vulgaris)
-
Acne is not a result of poor hygiene
- Constant washing does not improve acne
- Scrubbing dries and irritates skin further
IV. Management: General recommendations
V. Management: Medications
- See Topical Acne Vulgaris Management (Moderate Acne Vulgaris Management)
- See Systemic Acne Vulgaris Management (Severe Acne Vulgaris Management including Cystic Acne)
- See Adjunctive Acne Vulgaris Management
- Comedones
- Patients often present already having used Benzoyl Peroxide (OTC)
- Start with topical Retinoids (e.g. Retin A) at bedtime
- Mild Inflammatory Papules and Pustules
- Start with Benzoyl Peroxide in am AND Topical Retinoids (e.g. Retin A) at bedtime
- Adapalene with Benzoyl Peroxide (or without if not tolerated) is a preferred first line for mild to moderate acne
- Moderate Inflammatory Papules and Pustules
- Start with Benzoyl Peroxide in am AND Topical Retinoids (e.g. Retin A) at bedtime AND Oral Antibiotics
- If effective, then maintenance with topical Retinoids with or without Benzoyl Peroxide (and Antibiotics if severe)
- If ineffective, then advance to Isoretinoin (Accutane)
- Moderate to Severe Inflammatory Acne with Nodules
- Start with Benzoyl Peroxide in am AND Topical Retinoids (e.g. Retin A) at bedtime AND Topical Antibiotic
- If effective, then maintenance with topical Retinoids (with Benzoyl Peroxide and Antibiotics if severe)
- If ineffective, then advance to Isoretinoin (Accutane)
- Other measures
- Combined Oral Contraceptives with Spironolactone
- See Adjunctive Acne Vulgaris Management
- Consider if Menstrual Cycle associated acne or Hyperandrogenism related findings
- Combined Oral Contraceptives with Spironolactone
VI. Management: Skin of Color (e.g. black, asian, hispanic)
- Skin of Color is more susceptible to scarring, Keloids and Postinflammatory Hyperpigmentation
- Be aware of skin and hair products (e.g. cocoa butter, olive oil) that may exacerbate acne
- Many of these products are used more commonly in Skin of Color communities
- Start acne Topical Medications at less irritating, lower concentrations
- Increase dose slowly to reduce Postinflammatory Hyperpigmentation
- Retin A 0.025% cream every other day (instead of 0.05% gel daily)
- Benzoyl Peroxide 2.5% (instead of 5-10%)
- Azelaic Acid (Azelex, Finacea) may be indicated if Postinflammatory Hyperpigmentation is already present
VII. Management: Pregnancy
-
Acne Vulgaris outbreaks during pregnancy is associated with increased androgen levels in second and third trimesters
- Worsens in up to ~40% of pregnancies
-
General Measures
- Avoid oily cosmetics
- Perform facial cleansing twice daily
- Consider reducing dairy intake
- Avoid high Glycemic Foods
- Mild to Moderate Cases: Topicals safe in pregnancy
- Topical Benzoyl Peroxide 2.5 to 5%
- Azelaic Acid 15 to 20%
- Erythromycin Topical 2% (Erygel)
- Clindamycin Topical 1% (Cleocin-T)
- Severe cases
- Oral Erythromycin
- Oral Prednisone <20 mg/day for <1 month
- Pulsed Light Therapy
- Avoid Teratogens
- Avoid topical and oral Retinoids
- References
VIII. References
- Habif (2004) Dermatology, Mosby, p. 162-94
- Parker in Noble (2001) Primary Care p. 758-60
- Brown (1998) Lancet 351:1871-6 [PubMed]
- Feldman (2004) Am Fam Physician 69:2123-56 [PubMed]
- Gollnick (2003) J Am Acad Dermatol 49:S1-37 [PubMed]
- James (2005) N Engl J Med 352(14):1463-72 [PubMed]
- Oge (2019) Am Fam Physician 100(8): 475-84 [PubMed]
- Strauss (2007) J Am Acad Dermatol 56(4): 651-63 [PubMed]
- Titus (2012) Am Fam Physician 86(8): 734-40 [PubMed]